# Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes

> **NCT00591006** · PHASE3 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Phenytoin (brand name Dilantin)
- **DRUG:** Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00591006
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00591006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00591006, "Phenytoin as a Neuroprotective Agent Against Corticosteroid-induced Functional Imaging Changes". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00591006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*